Agenda
| 6:30 – 7:30 am | Registration Check-In Breakfast |
|---|---|
| 7:30 – 7:45 am | Welcome & Chairman’s Opening Remarks |
| Followed by 2013 Year in Review Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures Gilbert Kliman, MD, Managing Director – InterWest Partners William J. Link, PhD, Managing Director – Versant Ventures |
|
| 7:45 – 9:21 am | Private Device Company Showcase |
| Co-Moderators: Murthy V. Simhambhatla, PhD, Senior Vice President – Abbott Medical Group James Garvey, Chairman & Managing Partner – SV Life Sciences 7:45-7:53 – i-Optics Corporation – Jeroen Cammeraat, CEO 7:53-8:01 – Notal Vision – Scott Jones, President 8:01-8:09 – Clarity Medical – Keith Mullowney, Chairman & CEO 8:09-8:17 – WaveTec Vision Systems – Thomas Frinzi, President & CEO 8:17-8:25 – Refocus Group – Mike Judy, President & CEO 8:25-8:33 – PowerVision – Barry Cheskin, President & CEO 8:33-8:41 – AkkoLens International BV – Michiel Rombach, CEO 8:41-8:49 – AcuFocus – Nicholas Tarantino, OD, Chief Clinical & Regulatory Officer 8:49-8:57 – ClarVista Medical – Paul McLean, President & CEO 8:57-9:05 – Sinopsys Surgical – Harry Ross, President & CEO 9:05-9:13 – Sensimed AG – Jean-Marc Wismer, CEO 9:13-9:21 – Avedro – David Muller, PhD, President & CEO |
|
| 9:21 – 9:50 am | Morning Refreshment & Networking Break |
| 9:50 – 11:34 am | Private BioPharma Company Showcase |
| Co-Moderators: Theresa GH Heah, MD, Director of Brand Management & Global Marketing Ophthalmology – Bayer HealthCare Pharmaceuticals Neil Levine, Sr. Director, Marketing – Regeneron Pharmaceuticals 9:50-9:58 – Aerie Pharmaceuticals – Vicente Anido Jr., PhD, Chairman & CEO 9:58-10:06 – Amakem Therapeutics – Jack Elands, CEO 10:06-10:14 – Ocular Therapeutix – Amarpreet Sawhney, President & CEO 10:14-10:22 – RXi Pharmaceuticals – Geert Cauwenbergh, President & CEO 10:22-10:30 – Ophthotech Corporation – David Guyer, CEO 10:30-10:38 – Neurotech – Ted Danse, President & CEO 10:38-10:46 – Allegro Ophthalmics – Vicken Karageozian, Co-Founder & CTO 10:46-10:54 – PanOptica – Paul Chaney, President & CEO 10:54-11:02 – iCo Therapeutics – Andrew Rae, President & CEO 11:02-11:10 – Novaliq GmbH – Bernhard Gunther, CEO 11:10-11:18 – Eleven Biotherapeutics – Abbie Celniker, CEO 11:18-11:26 – Icon BioSciences – William S. (Sandy) White, President & CEO 11:26-11:34 – Kala Pharmaceuticals – Guillaume Pfefer, President & CEO |
|
| 11:34 – 11:59 am | Mobile Ophthalmic Technology Showcase |
| Moderator: Gilbert Kliman, MD, Managing Director – InterWest Partners 11:34-11:36 – Gobiquity Mobile Health – Michael Brownell, CEO 11:36-11:44 – Digisight – Doug Foster, CEO 11:44-11:49 – CheckedUp – Richard Awdeh, MD, Founder & CEO 11:49-11:54 – EyeNetra – David Schafran, Co-Founder & COO 11:54-11:59 – KeepYourSight – Marie Alexander, CEO |
|
| 11:59 am – 12:06 pm | The Ophthalmology Market |
| A View from the Public Sector Jeffrey Hoffman, Managing Director, Head of West Coast Healthcare Investment Banking – JPMorgan |
|
| 12:06 – 12:13 pm | Private Funding & Exit Trends |
| Jonathan Norris, Managing Director – SVB Capital | |
| 12:13 – 12:20 pm | US vs. EU |
| A Venture Perspective William J. Link, PhD, Managing Director – Versant Ventures |
|
| 12:20 pm | Luncheon Commences |
| 1:00 – 1:25 pm | Keynote: Sustaining Innovation in Ophthalmology |
| A View From the Top David E.I. Pyott, Chairman of the Board & CEO – Allergan |
|
| 1:25 – 1:50 pm | OIS Innovator Award |
| Recipients: Thomas Burns, President & CEO – Glaukos Richard Hill, MD, Co-Founder – Glaukos |
|
| 1:50 – 2:00 pm | Coffee & Networking |
| 2:00 pm | Luncheon Concludes |
| 2:00 – 2:07 pm | Ophthalmic Innovation 2013 |
| A View from the NEI Paul Sieving, MD, Director – National Eye Institute, National Institutes of Health |
|
| 2:07 – 2:50 pm | Ophthalmic Innovation 2013 |
| A View from the AAO David W. Parke, MD, CEO – American Academy of Ophthalmology |
|
| 2:15 – 2:50 pm | Developing an Effective Dialogue with the FDA |
| Moderator: Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures Panel Members: Wiley A. Chambers, MD, Deputy Director of the Division of Transplant & Ophthalmology Products, Center for Drug Evaluation & Research – FDA Malvina B. Eydelman, MD, Director, Division of Ophthalmic, Neurological & Ear, Nose & Throat Devices Office, Device Evaluation Center of Devices & Radiological Health – FDA |
|
| 2:50 – 3:20 pm | Alternative Financing Strategies |
| Moderator: Charles Warden, Managing Director – Versant Ventures Panel Members: Luke Duster, Principal – Capital Royalty Gregory Shearer, Managing Director – Healthios Capital Markets Brian Demmert, Managing Partner – Armentum Partners Buzz Benson, Managing Director – Sightline Partners |
|
| 3:20 – 3:50 pm | EU Commercialization Strategies |
| Moderator: Gilbert Kliman, MD, Managing Director – InterWest Partners Panel Members: Laurent Attias, Head, Global Commercial Strategy – Alcon David Muller, President & CEO – Avedro David E.I. Pyott, Chairman of the Board & CEO – Allergan James Mazzo, Operating Partner – Versant Ventures (Chairman – AcuFocus) |
|
| 3:50 – 4:20 pm | Afternoon Refreshment & Networking Break |
| 4:20 – 5:00 pm | Physician Entrepreneurship in Ophthalmology |
| Moderator: Richard L. Lindstrom, MD, Founder & Attending Surgeon – Minnesota Eye Consultants Panel Members: Mark S. Blumenkranz, MD, Professor & Chairman of the Department of Ophthalmology – Stanford University Eugene de Juan, MD, Founder & Vice Chairman – ForSight Labs David L. Epstein, MD, MMM, Joseph A.C. Wadsworth Clinical Professor of Ophthalmology & Chairman of Duke Eye Center – Duke University School of Medicine Steve Charles, MD, CEO – CamPlex Daniel Durrie, MD, Founder & President – Durrie Vision |
|
| 5:00 – 5:30 pm | Going Public |
| Who, When & Why? Moderator: David R. Guyer, MD, Chief Executive Officer – Ophthotech Panel Members: Jeffrey Hoffman, Managing Director, Head of West Coast Healthcare Investment Banking – JPMorgan Dan Myers, Co-Founder, President & CEO – Alimera Sciences Nicholas Galakatos, PhD, Managing Director – Clarus Ventures David E. Redlick, Partner & Co-Chair of the Life Sciences Group – WilmerHale Chris Cooley, CFA, Managing Director – Stephens |
|
| 5:30 – 5:35 pm | Wrap Up & Closing Comments |
| Emmett Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures Gilbert Kliman, MD, Managing Director – InterWest Partners William J. Link, PhD, Managing Director – Versant Ventures |
|
| 5:35 – 7:00 pm | Networking Reception |